SBIR/STTR Research Award

Multi-labeled material for in vivo cell tracking

Award identifier 62335577132bf245e28d6770d26147f2fa75862556660d442cbb6cefbbd1b797Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$407,937

Program and phase

SBIR · Phase II

Award year

2007

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIOPHYSICS ASSAY LABORATORY, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
KZDPB1XGZ6H1
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Cell-based therapies are rapidly gaining acceptance for use in treating a variety of diseases. The development of labels to non-radioactively track therapeutic cells in vivo is needed to measure the efficacy of delivery systems, bio-distribution and effective dose. In Vivo Survey Technology" (IVST) is a label material designed to be assayed by a number of measurement technologies and able to be readily taken up by cells. IVST is beginning to be used by scientists to determine the quantity and location of cells, such as stem cells, transplanted during preclinical research. In Phase I, multi-detection nano- materials were successfully prepared that combined neutron activation analysis, electron microscopy, fluorescent imaging and magnetic resonance imaging. This Phase II application seeks support to optimize the labeling of cells with IVST materials, to demonstrate that all measurements can be performed with the newly developed IVST nano-particles and to compare a variety of coatings that can target IVST particles to specific cell types. IVST will allow researchers to conduct analyses on cell therapy protocols not readily feasible previously and to obtain badly needed basic information to optimize for success in clinical trials. The project will develop tools that allow researchers to track, identify, and measure the amount of implanted cell in living subjects over long periods of time. These tools will aid our understanding of specific disease processes. In addition, these tools are necessary to evaluate the usefulness and safety of cell-based therapies.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

19 SBIR/STTR records share this UEI (1999–2013). Reported award amounts total $5,794,307. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.